LABORATOIRE D'INNOVATION VEGETALE

Name

LABORATOIRE D'INNOVATION VEGETALE

Legal name

LABORATOIRE D'INNOVATION VEGETALE

Website

https://liv.fr

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Contract Manufacturing Services for Food Supplements

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Contract manufacturing
• Food supplements
• Galenic formulation
• Dietary supplements
• Organic certified production

Headquarters

HQ city

Le Pouzin

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: LIV generates revenue through contract manufacturing of food supplements, offering flexible arrangements including supply of bulk or packaged products, manufacturing from their raw material catalogue or client-provided ingredients, and complete subcontracting services. Revenue is project-based with customization according to client specifications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

LABORATOIRE D'INNOVATION VEGETALE (LIV) is a French B2B contract manufacturer of food supplements, producing tablets, capsules, powder sachets, stick packs, powder jars, syrups, and plant-complex liquid products for brand clients. The company operates two certified industrial sites (Le Pouzin and Châteaugiron), manages the full process from formulation and trial batches to industrial-scale manufacturing and packaging, and provides regulatory documentation support for the French market and export destinations.

Product overview

LABORATOIRE D'INNOVATION VEGETALE (LIV) is a contract manufacturer of food supplements offering a comprehensive portfolio of galenic formulations and packaging solutions. The company operates two certified industrial sites in Brittany and Rhône-Alpes, providing end-to-end services from product development and trial batches to industrial-scale manufacturing. The product portfolio includes dry formats (tablets, capsules, powder sachets, stick packs, powder jars) and liquid formats (syrups, plant complexes, buds), with various packaging options (blisters, bottles, tubes). LIV supports both conventional and organic-certified products, with capabilities spanning formulation design, manufacturing, quality control, and regulatory documentation for France and export markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services for Food Supplements End-to-end B2B contract manufacturing service for food supplements, covering formulation support, trial batches, industrial-scale production, packaging, regulatory documentation for France and export markets, and logistics follow-up. Customers can commission bulk or packaged finished products, manufacture from LIV's raw material catalogue or from client-supplied ingredients, or opt for full subcontracting.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• GolgemmacoreStrategic or Co-development PartnerSister company located in Rhône-Alpes specializing in the manufacture of liquid extracts from locally sourced organic and conventional plants. Golgemma provides extraction expertise that complements LIV's formulation and manufacturing capabilities, enabling LIV to offer liquid product formulations including syrups, plant complexes, and buds.
• Biolandes GroupcoreOthersParent company group of which LIV is a part. The Biolandes Group encompasses multiple companies in the plant extraction and food supplement manufacturing sector. LIV operates under the Group's ethics charter and anti-corruption code of conduct policies.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Corden Pharma: European pharmaceutical CDMO with capabilities spanning oral solid dosage forms through to liquid formulations. Comparable contract manufacturing model serving health-product brand owners across Europe.
• Aenova Group: European pharmaceutical CDMO with a strong presence in dietary supplement manufacturing, including softgels, tablets, and capsules. Comparable in offering end-to-end contract manufacturing services to supplement brand owners.
• Sirio Pharma: Global dietary supplement and nutrition CDMO with manufacturing sites in Asia, Europe, and North America. Directly comparable as a B2B contract manufacturer of supplements across solid and liquid galenic forms.
• Delpharm: One of France's largest pharmaceutical contract manufacturers with full galenic capabilities including tablets, capsules, and liquid forms. Directly competes with LIV for European contract manufacturing of health and supplement products from French industrial sites.
• Recipharm: Swedish-headquartered European CDMO with broad solid and semi-solid dosage form manufacturing. Operates multiple continental production sites and competes directly for European supplement contract manufacturing business.

Broad incumbents

• Almac Group: Northern Irish-headquartered global pharmaceutical CDMO with broad solid dose and packaging capabilities. Acts as a much larger comparable for CDMO services in regulated health and supplement products.
• Catalent: Global pharmaceutical and consumer health CDMO with extensive supplement, softgel, and oral solid dose capabilities. Operates at significantly larger scale; competes for the broader European CDMO work that LIV also targets.

Others

• Eurofins: French-rooted bioanalytical testing and product development services group with adjacent CDMO and nutraceutical testing capabilities. Ecosystem participant that intersects with LIV's quality and regulatory support services rather than directly competing on supplement manufacturing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/liv-laboratoire-innovation-vegetale

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LABORATOIRE D'INNOVATION VEGETALE